Dual vs Triple Therapy Following ACS or PCI in Patients with Atrial Fibrillation

Objective. To compare the benefit of apixaban with a vitamin K antagonist and compare aspirin with placebo in patients with atrial fibrillation who had acute coronary syndrome or underwent percutaneous coronary intervention (PCI) and were planning to take a P2Y12 inhibitor. Design. Multicenter, inte...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical outcomes management 2019-11, Vol.26 (6), p.1509
Hauptverfasser:	Hirai, Taishi, Blair, John
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute coronary syndromes Anticoagulants Cardiac arrhythmia Clinical outcomes Drug therapy Inhibitor drugs
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!